HIGHLIGHTS
- who: Stine Bangsgaard Hansen from the Germany Cell Cure, Cardiology Stem Cell Centre, The Heart Centre, University Hospital Rigshospitalet have published the Article: Optimizing an immunomodulatory potency assay for Mesenchymal Stromal Cell, in the Journal: (JOURNAL)
- what: The authors aimed to investigate and optimize factors to obtain the most feasible and robust potency assay to quantify the suppressive effect of ASC on lymphocyte proliferation. PWM was dropped from the study as the data did not allow for analysis, i.e., absence of proliferation and distinct CFSE peaks. except CFSE-labeling prior to cryopreservation, for which . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.